The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
Morgan Stanley Pathway Intl Eq TIEUX
- NAV / 1-Day Return 13.48 / −0.30 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.680%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.96%
- Turnover 33%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0
Morningstar’s Analysis TIEUX
Will TIEUX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 14.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Us Dollars | 3.13 | 39.2 Mil | Cash and Equivalents |
Novo Nordisk A/S Class B | 1.97 | 24.7 Mil | Healthcare |
SAP SE | 1.80 | 22.5 Mil | Technology |
Roche Holding AG | 1.73 | 21.7 Mil | Healthcare |
ASML Holding NV | 1.67 | 21.0 Mil | Technology |
Shell PLC | 1.42 | 17.8 Mil | Energy |
Novartis AG Registered Shares | 1.18 | 14.8 Mil | Healthcare |
AstraZeneca PLC | 1.18 | 14.7 Mil | Healthcare |
Nestle SA | 1.15 | 14.4 Mil | Consumer Defensive |
Rolls-Royce Holdings PLC | 1.14 | 14.2 Mil | Industrials |